title: Irinotecan plus mitomycin C as second-line chemotherapy for advanced gastric cancer resistant to fluoropyrimidine and Cisplatin: a retrospective study.
abstract: Background. S-1 plus cisplatin has been established to be standard first-line chemotherapy for advanced gastric cancer in Japan. The optimal second-line treatment refractory to S-1 plus cisplatin remains unclear. Methods. We retrospectively studied the efficacy, toxicity, and survival of irinotecan plus mitomycin C in patients with advanced gastric cancer refractory to a fluoropyrimidine plus cisplatin. Results. Twenty-four patients were studied. Prior chemotherapy was S-1 plus cisplatin in 15 patients, S-1 plus cisplatin and docetaxel in 8, and 5-fluorouracil plus cisplatin with radiotherapy in 1. The overall response rate was 17.4%. The median overall survival was 8.6 months, and the median progression-free survival was 3.6 months. Grade 3 or 4 toxicities included leukopenia (33%), neutropenia (50%), anemia (33%), thrombocytopenia (4%), anorexia (13%), diarrhea (4%), and febrile neutropenia (13%). Conclusion. A combination of irinotecan and mitomycin C is potentially effective in patients with advanced gastric cancer refractory to a fluoropyrimidine plus cisplatin.
authors.affiliation: Department of Gastroenterology and Hematology, Faculty of Medicine, University of Toyama, 2630 Sugitani, Toyama 930-0194, Japan.
authors.forename: Kohei
authors.initials: K
authors.lastname: Ogawa
authors.forename: Ayumu
authors.initials: A
authors.lastname: Hosokawa
authors.forename: Akira
authors.initials: A
authors.lastname: Ueda
authors.forename: Seiko
authors.initials: S
authors.lastname: Saito
authors.forename: Hiroshi
authors.initials: H
authors.lastname: Mihara
authors.forename: Takayuki
authors.initials: T
authors.lastname: Ando
authors.forename: Shinya
authors.initials: S
authors.lastname: Kajiura
authors.forename: Mitsuhiro
authors.initials: M
authors.lastname: Terada
authors.forename: Yuji
authors.initials: Y
authors.lastname: Tsukioka
authors.forename: Naoki
authors.initials: N
authors.lastname: Horikawa
authors.forename: Takashi
authors.initials: T
authors.lastname: Kobayashi
authors.forename: Masayuki
authors.initials: M
authors.lastname: Note
authors.forename: Kunihiro
authors.initials: K
authors.lastname: Sawasaki
authors.forename: Junya
authors.initials: J
authors.lastname: Fukuoka
authors.forename: Toshiro
authors.initials: T
authors.lastname: Sugiyama